News Archives

News Archives

Demand for OxC-beta™ Livestock Continues to Grow as Avivagen Secures Another Order in Asia-Pacific

Ottawa, ON /Business Wire/ August 26, 2019 / Avivagen Inc. (TSXV:VIV) (“Avivagen”) has secured a new order for two metric tons of OxC-betaTM Livestock (“OxC-beta”) from UNAHCO, its partner in the Philippines. The new order marks the third multi-metric ton order of OxC-betaTM  Livestock by UNAHCO in the past 10 months, helping the company meet …Read More

Avivagen Announces Approval for OxC-beta™ Livestock (“OxC-beta”) in Mexico

Avivagen Inc. (TSXV:VIV) is pleased to announce that it has received approval for OxC-beta™ Livestock (“OxC-beta”) in Mexico.

Avivagen Director Aubrey Dan Named Member of the Order of Canada

Ottawa, ON and Toronto, ON / Business Wire / July 23, 2019/ Avivagen (TSXV:VIV) (“Avivagen” or the Corporation), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce that Mr. Aubrey Dan has been named a Member of the Order of …Read More

Avivagen and Mimi’s Rock Announce Joint Venture for the Companion Animal Market

State of the art e-commerce platform to offer exclusive products for the pet market Ottawa, ON and Toronto, ON / Business Wire / June 13, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), owner of the intellectual property protected OxC-beta™ technology that supports the optimal health of companion animals, and Mimi’s Rock Corp. …Read More

Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2019

An increase of 73% in sales over the six-month period Ottawa, ON /Business Wire/ June 4, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a world leader in natural alternatives to antibiotics with its OXC-beta™ technology, reported today its unaudited financial results for the second quarter of 2019 and Stock Option plan update. …Read More

Avivagen Announces Officer Changes

Ottawa, ON / Business Wire / May 14, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces the appointments of Mr. Kym Anthony to the position …Read More